— Amarin Corporation plc (NASDAQ: AMRN) reported earnings of $0.04 per share in the fourth-quarter 2019 vs. $0.02 per share loss expected.
— Revenue grew 85% to $143.3 million, versus $136.01 million expected. Net product revenue increased 84% year-over-year to $142 million, driven mainly by an increase in total Vascepa prescriptions in the US.
— For full-year 2020, Amarin expects revenues to be $650 million to $700 million.
— AMRN shares gained 2% during the aftermarket hours.
Most Popular
Infographic: How Lennar Corporation (LEN) performed in Q3 2024
Lennar Corporation (NYSE: LEN) reported total revenues of $9.4 billion for the third quarter of 2024, which was up 8% from the same period last year. Net earnings attributable to
FDX Earnings: FedEx Q1 2025 revenue and profit miss analysts’ estimates
Cargo giant FedEx Corporation (NYSE: FDX) Thursday reported a decrease in revenues and adjusted earnings for the first quarter of 2025. The results also fell short of expectations. First-quarter earnings,
Signet (SIG) remains optimistic about its fiscal year 2025 performance, here’s why
Shares of Signet Jewelers Limited (NYSE: SIG) were up over 4% on Thursday. The stock has gained 24% over the past one month. The jewelry retailer saw revenue and profits
